TGF-β signaling from receptors to the nucleus

Microbes and Infection

Volumn 1, Issue 15, 1999, Pages 1265-1273

  Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Signal transduction; Smad; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; GENE TARGETING; IMMUNOREGULATION; INFLAMMATION; LEUKEMOGENESIS; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0033380665     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00258-0     Document Type: Review

References (64)

1. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16:1998;137-161.
2. Derynck R., Zhang Y., Feng X.H. Smads transcriptional activators of TGF-beta responses. Cell. 95:1998;737-740.
3. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
4. Derynck R., Feng X.H. TGF-beta receptor signaling. Biochim. Biophys. Acta. 1333:(F):1997;105-150.
5. Padgett R.W., Das P., Krishna S. TGF-beta signaling Smads and tumor suppressors. Bioessays. 20:1998;382-390.
6. Darnell J.E. Jr.,. STATs and gene regulation. Science. 277:1997;1630-1635.
7. Heldin C.H., Miyazono K., TenDijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
8. Attisano L., Wrana J.L. Mads and Smads in TGF beta signalling. Curr. Opin. Cell Biol. 10:1998;188-194.
9. Wieser R., Wrana J.L., Massague J. GS domain mutations that constitutively activate T beta R-I the downstream signaling component in the TGF-beta receptor complex. EMBO J. 14:1995;2199-2208.
10. Lux A., Attisano L., Marchuk D. Assignment of TGF-β1 β3 and a third new ligand to the type I receptor ALK-1. J. Biol. Chem. 274:1999;9984-9992.
11. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C.H., Miyazono K., TenDijke P. TGF-beta receptor-mediated signalling through Smad2 Smad3 and Smad4. EMBO J. 16:1997;5353-5362.
12. Eppert K., Scherer S.W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L.C., Bapat B., Gallinger S., Andrulis I.L., Thomsen G.H., Wrana J.L., Attisano L. MADR2 maps to 18q21 and encodes a TGF-beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 86:1996;543-552.
13. Kawabata M., Imamura T., Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor. Rev. 9:1998;49-61.
14. Liu X.J., Yue J.B., Frey R.S., Zhu Q.C., Mulder K.M. Transforming growth factor beta signaling through smad1 in human breast cancer cells. Cancer Research. 58:1998;4752-4757.
15. Bruno E., Horrigan S.K., Van DenBerg D., Rozler E., Fitting P.R., Moss S.T., Westbrook C., Hoffman R. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood. 91:1998;1917-1923.
16. Abdollah S., Macias-Silva M., Tsukazaki T., Hayashi H., Attisano L., Wrana J.L. TGF-beta RI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272:1997;27678-27685.
17. Souchelnytskyi S., Tamaki K., Engstrom U., Wernstedt C., TenDijke P., Heldin C.H. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J. Biol. Chem. 272:1997;28107-28115.
18. Chen Y.G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., Massague J. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12:1998;2144-2152.
19. Hata A., Lo R.S., Wotton D., Lagna G., Massague J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature. 388:1997;82-87.
20. Tsukazaki T., Chiang T.A., Davison A.F., Attisano L., Wrana J.L. SARA a FYVE domain protein that recruits Smad2 to the TGF-beta receptor. Cell. 95:1998;779-791.
21. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., DaCosta L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. DPC4 a candidate tumor suppressor gene at human chromosome 18q21. Science. 271:1996;350-353.
22. Grady W.M., Myerhoff L.L., Swinler S.E., Rajput A., Thiagalingam S., Lutterbaugh J.D., Neumann A., Brattain M.G., Chang J., Kim S.J., Kinzler K.W., Vogelstein B., Willson J.K.V., Markowitz S. Mutational inactivation of transforming growth factor b receptor type II in microsatellite stable colon cancers. Cancer Res. 59:1999;320-324.
23. Lagna G., Hata A., Hemmati-Brivanlou A., Massague J. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. 383:1996;832-836.
24. Candia A.F., Watabe T., Hawley S.H., Onichtchouk D., Zhang Y., Derynck R., Niehrs C., Cho K.W. Cellular interpretation of multiple TGF-beta signals intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development. 124:1997;4467-4480.
25. Shi Y., Hata A., Lo R.S., Massague J., Pavletich N.P. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 388:1997;87-93.
26. Kawabata M., Inoue H., Hanyu A., Imamura T., Miyazono K. Smad proteins exist as monomers in vivo and undergo homo- and hetero- oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:1998;4056-4065.
27. Howe J.R., Roth S., Ringold J.C., Summers R.W., Jarvinen H.J., Sistonen P., Tomlinson I.P., Houlston R.S., Bevan S., Mitros F.A., Stone E.M., Aaltonen L.A. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 280:1998;1086-1088.
28. De Caestecker M.P., Hemmati P., Larisch-Bloch S., Ajmera R., Roberts A.B., Lechleider R.J. Characterization of functional domains within Smad4/DPC4. J. Biol. Chem. 272:1997;13690-13696.
29. Topper J.N., Cai J., Qiu Y., Anderson K.R., Xu Y.Y., Deeds J.D., Feeley R., Gimeno C.J., Woolf E.A., Tayber O., Mays G.G., Sampson B.A., Schoen F.J., GimbroneJr M.A., Falb D. Vascular MADs two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA. 94:1997;9314-9319.
30. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., Miyazono K. Smad6 inhibits signalling by the TGF-beta superfamily. Nature. 389:1997;622-626.
31. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., TenDijke P. Identification of Smad7 a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389:1997;631-635.
32. Pawson T., Scott J.D. Signaling through scaffold anchoring and adaptor proteins. Science. 278:1997;2075-2080.
33. Tsuneizumi K., Nakayama T., Kamoshida Y., Kornberg T.B., Christian J.L., Tabata T. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature. 389:1997;627-631.
34. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119.
35. Afrakhte M., Moren A., Jossan S., Itoh S., Sampath K., Westermark B., Heldin C.H., Heldin N.E., TenDijke P. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem. Biophys. Res. Commun. 249:1998;505-511.
36. Itoh S., Landstrom M., Hermansson A., Itoh F., Heldin C.H., Heldin N.E., TenDijke P. Transforming growth factor beta 1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:1998;29195-29201.
37. Vindevoghel L., Lechleider R.J., Kon A., DeCaestecker M.P., Uitto J., Roberts A.B., Mauviel A. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc. Natl. Acad. Sci. USA. 95:1998;14769-14774.
38. Yagi K., Goto D., Hamamoto T., Takenoshita S., Kato M., Miyazono K. Alternatively spliced variant of Smad2 lacking exon 3, Comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274:1999;703-709.
39. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kern S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell. 1:1998;611-617.
40. Hua X., Liu X., Ansari D.O., Lodish H.F. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12:1998;3084-3095.
41. Dennler S., Itoh S., Vivien D., TenDijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
42. Song C.Z., Siok T.E., Gelehrter T.D. Smad4/DPC4 and smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter. J. Biol. Chem. 273:1998;29287-29290.
43. Jonk L.J., Itoh S., Heldin C.H., TenDijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta activin and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273:1998;21145-21152.
44. Yingling J.M., Datto M.B., Wong C., Frederick J.P., Liberati N.T., Wang X.F. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol. Cell Biol. 17:1997;7019-7028.
45. Shi Y., Wang Y.F., Jayaraman L., Yang H., Massague J., Pavletich N.P. Crystal structure of a Smad MH1 domain bound to DNA insights on DNA binding in TGF-beta signaling. Cell. 94:1998;585-594.
46. Chen X., Weisberg E., Fridmacher V., Watanabe M., Naco G., Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature. 389:1997;85-89.
47. Zhang Y., Feng X.H., Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature. 394:1998;909-913.
48. Kurokawa M., Mitani K., Irie K., Matsuyama T., Takahashi T., Chiba S., Yazaki Y., Matsumoto K., Hirai H. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature. 394:1998;92-96.
49. Moustakas A., Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA. 95:1998;6733-6738.
50. Feng X.H., Zhang Y., Wu R.Y., Derynck R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. Genes Dev. 12:1998;2153-2163.
51. Topper J.N., Dichiara M.R., Brown J.D., Williams A.J., Falb D., Collins T., Gimbrone M.A.J. CREB binding protein is a required coactivator for Smad-dependent transforming growth factor beta transcriptional responses in endothelial cells. Proc. Natl. Acad. Sci. USA. 95:1998;9506-9511.
52. Shioda T., Lechleider R.J., Dunwoodie S.L., Li H., Yahata T., DeCaestecker M.P., Fenner M.H., Roberts A.B., Isselbacher K.J. Transcriptional activating activity of Smad4 roles of SMAD hetero- oligomerization and enhancement by an associating transactivator. Proc. Natl. Acad. Sci. USA. 95:1998;9785-9790.
53. Kretzschmar M., Doody J., Massague J. Opposing BMP and EGF signalling pathways converge on the TGF- beta family mediator Smad1. Nature. 389:1997;618-622.
54. DeCaestecker M.P., Parks W.T., Frank C.J., Castagnino P., Bottaro D.P., Roberts A.B., Lechleider R.J. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12:1998;1587-1592.
55. Brown J.D., Dichiara M.R., Anderson K.R., Gimbrone M.A.J., Topper J.N. MEKK-1 a component of the stress (Stress-activated Protein Kinase/c- Jun N-terminal Kinase) pathway can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J. Biol. Chem. 1999;2748797-2748805.
56. Ulloa L., Doody J., Massagué J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 1999;397710-397713.
57. Bright J.J., Kerr L.D., Sriram S. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat-5 in T lymphocytes. J. Immunol. 159:1997;175-183.
58. Pardoux C., Ma X., Gobert S., Pellegrini S., Mayeux P., Gay F., Trinchieri G., Chouaib S. Downregulation of Interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-b relationship with IL-12 signaling. Blood. 93:1999;1448-1455.
59. Yang X., Letterio J.J., Chen L., Hayman R., Lechleider R.J., Gu H., Roberts A.B., Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β EMBO J. 1999;181280-181291.
60. Ashcroft G.S., Yang X., Glick A., Weinstein M., Letterio J.J., Mizel D.E., Anzano M., Greenwell-Wild T., Wahl S.M., Deng C., Roberts A.B. Mice lacking SMAD3 show accelerated wound healing and an inpaired local inflamatory response. Nature Cell Biol. 1:1999;260-266.
61. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell. 92:1998;797-808.
62. Nomura M., Li E. Smad2 role in mesoderm formation left-right patterning and craniofacial development. Nature. 393:1998;786-790.
63. Sirard C., De LaPompa J.L., Elia A., Itie A., Mirtsos C., Cheung A., Hahn S., Wakeham A., Schwartz L., Kern S.E., Rossant J., Mak T.W. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12:1998;107-119.
64. Kurokawa M., Mitani K., Imai Y., Ogawa S., Yazaki Y., Hirai H. The t (3;21) fusion product AML1/Evi-1 interacts with smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. Blood. 92:1998;4003-4012.